Inflammation induction of Dickkopf-1 mediates chondrocyte apoptosis in osteoarthritic joint

L-H Weng1, C-J Wang, J-Y Ko

  • 1Department of Orthopedic Surgery, Chang Gung Memorial Hospital Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan.

Abstract

Insights

Dickkopf-1 (DKK1) expression correlates with osteoarthritis (OA) progression and chondrocyte apoptosis. Inhibiting DKK1 may reduce cartilage damage in OA by preventing inflammatory responses and cell death.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Orthopedics

Background:

  • Dysregulated Wnt signaling is implicated in chondrocyte dysfunction and joint disorders.
  • Dickkopf-1 (DKK1), an inhibitor of Wnt signaling, plays a role in skeletal tissue pathogenesis.
  • The relationship between DKK1 expression and chondrocyte fate in osteoarthritis (OA) requires investigation.

Purpose of the Study:

  • To examine the link between Dickkopf-1 (DKK1) expression and chondrocyte fate in osteoarthritis (OA).
  • To investigate the role of DKK1 in mediating inflammation-induced chondrocyte apoptosis.

Main Methods:

  • Articular cartilage from OA patients and controls were analyzed for DKK1, inflammatory cytokines (IL-1beta, TNF-alpha), and apoptosis markers using RT-PCR and immunohistochemistry.
  • Chondrocyte apoptosis was assessed via TUNEL and DAPI staining.
  • Human chondrocyte cultures were treated with IL-1beta and anti-DKK1 antibodies to evaluate DKK1's effect on chondrocyte survival.

Main Results:

  • DKK1 expression positively correlated with inflammatory cytokines (IL-1beta, TNF-alpha) and pro-apoptotic markers (Bad, caspase-3) in OA cartilage.
  • Interleukin-1beta (IL-1beta) induced DKK1 expression and subsequent chondrocyte apoptosis.
  • Neutralization of DKK1 inhibited IL-1beta-induced apoptosis and restored chondrocyte proliferation, while recombinant DKK1 promoted apoptosis.

Conclusions:

  • Chondrocyte apoptosis is a key feature of osteoarthritis (OA).
  • DKK1 expression contributes significantly to cartilage degradation and OA pathogenesis.
  • Targeting DKK1 presents a potential therapeutic strategy to mitigate cartilage deterioration in OA.